| Pioneer factor Pax7 deploys a stable enhancer repertoire for specification of cell fate A Mayran, K Khetchoumian, F Hariri, T Pastinen, Y Gauthier, A Balsalobre, ... Nature genetics 50 (2), 259-269, 2018 | 148 | 2018 |
| A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients JL Guéant, C Chéry, A Oussalah, J Nadaf, D Coelho, T Josse, J Flayac, ... Nature Communications 9 (1), 67, 2018 | 83 | 2018 |
| Promoter capture Hi-C-based identification of recurrent noncoding mutations in colorectal cancer G Orlando, PJ Law, AJ Cornish, SE Dobbins, D Chubb, P Broderick, ... Nature genetics 50 (10), 1375-1380, 2018 | 62 | 2018 |
| The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia F Hariri, M Arguello, L Volpon, B Culjkovic-Kraljacic, TH Nielsen, J Hiscott, ... Leukemia 27 (10), 2047-2055, 2013 | 36 | 2013 |
| Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma A Sud, H Thomsen, G Orlando, A Foersti, PJ Law, P Broderick, R Cooke, ... Blood, The Journal of the American Society of Hematology 132 (19), 2040-2052, 2018 | 29 | 2018 |
| Regulation of de novo ceramide synthesis: the role of dihydroceramide desaturase and transcriptional factors NFATC and Hand2 in the hypoxic mouse heart R Azzam, F Hariri, N El-Hachem, A Kamar, G Dbaibo, G Nemer, F Bitar DNA and cell biology 32 (6), 310-319, 2013 | 25 | 2013 |
| Genetic predisposition to multiple myeloma at 5q15 is mediated by an ELL2 enhancer polymorphism N Li, DC Johnson, N Weinhold, S Kimber, SE Dobbins, JS Mitchell, ... Cell reports 20 (11), 2556-2564, 2017 | 23 | 2017 |
| T-box factors: insights into the evolutionary emergence of the complex heart F Hariri, M Nemer, G Nemer Annals of Medicine 44 (7), 680-693, 2012 | 19 | 2012 |
| APRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients. Nat Commun 9: 67 JL Guéant, C Chéry, A Oussalah, J Nadaf, D Coelho, T Josse, J Flayac, ... | 6 | 2018 |
| Understanding the transcriptional control of EIF4E and its dysregulation in acute myeloid leukemia: role of NF-κB F Hariri | | 2015 |
| The Eukaryotic Translation Initiation Factor eIF4E, a Recently Identified Therapeutic Target In AML, Is a Direct Transcriptional Target of NFkB F Hariri, M Arguello, B Culjkovic, A Amri, K Borden Blood 116 (21), 3146, 2010 | | 2010 |
| Introduction to the Field of Fusion Energy and the role of Turbulence and Disruptions G Antar, T El-Souss, R Hajjar, F Hariri, W Kassem, L Moubarak, ... | | |
